You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
Sodium Butyrate has been reported to cause hyperacetylation of histones due to its role as a histone deacetylase (HDAC) inhibitor (IC50 values are 0.3, 0.4, 0.3, mM for HDAC1, 2 and 7 respectively). This compound has been shown to cause induction of differentiation and gene expression and also prevent cell proliferation. Mechanistic studies suggest that the action of Sodium Butyrate is often mediated through Sp1/Sp3-associated HDAC activity which leads to transcriptional activation of the p21 gene. Additionally this agent demonstrates the ability to downregulate numerous genes associated with cytokine signaling, specifically, the IFN-γ (interferon γ) pathway.
1. Sealy, L., et al., 1978. The effect of sodium butyrate on histone modification. Cell. 14(1): 115-21. PMID: 667928
2. Davie, James R., et al., 2003. Inhibition of histone deacetylase activity by butyrate. The Journal of nutrition. 133(7 Suppl): 2485S-2493S. PMID: 12840228
3. Joseph, Jeena., et al., 2004. Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene. 23(37): 6304-15. PMID: 15318170
4. Sekhavat, Anoushe., et al., 2007. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochemistry and cell biology = Biochimie et biologie cellulaire. 85(6): 751-8. PMID: 18059533
See how others have used Sodium Butyrate. Click on the entry to view the PubMed entry .
PMID: # 29235036 Ho, CF.|Bon, CP.|Ng, YK.|Herr, DR.|Wu, JS.|Lin, TN.|Ong, WY.| et al. 2018. Neurochem. Res. 43: 540-555.
PMID: # 25342559 Yang, Y. et al. 2014. Cell Res. 24: 1342-53.
PMID: # 17967882 Pesavento, JJ. et al. 2008. Mol. Cell. Biol. 28: 468-486.
PMID: # 17881451 Neumann, DM. et al. 2007. J. Virol. 81: 13248-13253.
PMID: # 16699007 Lu, F. et al. 2006. J. Virol. 80: 5273-5282.
PMID: # 12654818 Scaife, H. et al. 2003. Infect. Immun. 71: 1995-2001.
PMID: # 11884567 Chiou, CJ. et al. 2002. J. Virol. 76: 3421-3439.
PMID: # 10639456 Gerçeker, AA. et al. 2000. Infect. Immun. 68: 861-870.
PMID: # 9971760 Gasmi, M. et al. 1999. J. Virol. 73: 1828-1834.
PMID: # 30720434 Elife. 8:
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.